PL EN


Preferences help
enabled [disable] Abstract
Number of results
2002 | 56 | 6 | 789-801
Article title

Magic bullets ? monoclonal antibodies in acute leukaemias and non-Hodgkin lymphomas treatment

Content
Title variants
Languages of publication
PL
Abstracts
EN
Because of high percent of failures in haematologic malignancies treatment there is a need of discovering new drugs. One of the new approaches are monoclonal antibodies, which target specific cluster differentiation antigens on tumor cells. Rituximab is an anti-CD20 antibody used in non-Hodgkin lymphoma, alemtuzumab - in B chronic lymphocytic leukaemia, gemtuzumab ozogamicin ? in non-lymphoblastic leukaemia, tositumomab and ibritumomab are monoclonal antibodies binded with radiopharmaceutics and are used in non-Hodgkin lymphomas.
References
Document Type
ARTICLE
Publication order reference
W. Luczynski, Klinika Onkologii Dzieciecej Akademii Medycznej, ul. Waszyngtona 17, 15-274 Bialystok, Poland
YADDA identifier
bwmeta1.element.element-from-psjc-18a117dd-7168-3ff8-9b2d-a4152ddc9c0c
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.